If & when FDA approve this will revalue where all long term...

If & when FDA approve this will revalue where all long term suffering shareholders will come out in black, that's when I plan to exit.
Big question is do they have enough cash to get through these clinical trials while paying continue increase and pay themselves millions in management salaries. Very critical of management as these studies should have been done at least 5 years ago while plandering millions of dollars into a failed go2 market strategy and salaries
Boston Scientific are going to have to reevaluate their TAVR strategy with recent study results presented at TCT. So be interesting to see how this plays out with Medtronic as could be hunt for alternatives. You can imagine the chat in those M&A departments of these companies in Minneapolis doing their due diligence..... you know that little aussie company s, they have little skin in the game, their share price is equivalent of 3 bags of carrots, and they are paid big salaries WTF, hmmm ??